ダウンロード数: 653
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
48_427.pdf | 763.22 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 塚本, 哲郎 | ja |
dc.contributor.author | 米瀬, 淳二 | ja |
dc.contributor.author | 石井, 信行 | ja |
dc.contributor.author | 前澤, 卓也 | ja |
dc.contributor.author | 福井, 巖 | ja |
dc.contributor.alternative | Tsukamoto, Tetsuro | en |
dc.contributor.alternative | Yonese, Junji | en |
dc.contributor.alternative | Ishii, Nobuyuki | en |
dc.contributor.alternative | Maezawa, Takuya | en |
dc.contributor.alternative | Fukui, Iwao | en |
dc.date.accessioned | 2010-05-27T07:14:16Z | - |
dc.date.available | 2010-05-27T07:14:16Z | - |
dc.date.issued | 2002-07 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/114789 | - |
dc.description.abstract | 35歳男.前化学療法(ifosfamide, 5-FU, etoposide, cisplatinの併用)に抵抗性を示し, 標題の3者併用療法によって完全緩解した.副作用として好中球減少と血小板減少を認めたが容認できる範囲と考えられた | ja |
dc.description.abstract | A 35-year-old man who had undergone nephroureterectomy and a single cycle of adjuvant MVAC chemotherapy for the left ureteral cancer was referred our clinic for the treatment of paraaortic lymph node metastases. Following histologic confirmation of transitional cell carcinoma by computed tomography (CT) guided biopsy, we treated him with combination chemotherapy consisting of ifosfamide, 5-fluorouracil, etoposide and cisplatin. After 5 cycles of chemotherapy complete remission was obtained. Six months later, however, metastases recurred in the left supraclavicular and paraaortic lymph nodes. Thus, we treated him with a new combination chemotherapy comprising gemcitabine, etoposide and cisplatin which was approved as a phase I study by the institutional review board. Although he was the first patient enrolled in the study and received the minimum dose of gemcitabine (level 1), complete remission was again achieved. Adjuvant radiotherapy of 40 Gy was given to the metastatic sites. He has been well without evidence of disease for 12 months. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.subject | Adult | en |
dc.subject | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | en |
dc.subject | Carcinoma, Transitional Cell/therapy | en |
dc.subject | Cisplatin/administration & dosage | en |
dc.subject | Deoxycytidine/administration & dosage/analogs & derivatives | en |
dc.subject | Etoposide/administration & dosage | en |
dc.subject | Humans | en |
dc.subject | Lymphatic Metastasis | en |
dc.subject | Male | en |
dc.subject | Radiotherapy, Adjuvant | en |
dc.subject | Remission Induction | en |
dc.subject | Salvage Therapy | en |
dc.subject | Treatment Outcome | en |
dc.subject | Ureteral Neoplasms/therapy | en |
dc.subject.ndc | 494.9 | - |
dc.title | サルベージ化学療法としてgemcitabine,etoposide,cisplatinの3者併用化学療法が奏効した転移性尿管癌の1例 | ja |
dc.title.alternative | Successful salvage chemotherapy with gemcitabine, etoposide and cisplatin for metastatic ureteral cancer: a case report | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 48 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 427 | - |
dc.identifier.epage | 430 | - |
dc.textversion | publisher | - |
dc.sortkey | 06 | - |
dc.address | 癌研究会附属病院 泌尿器科 | ja |
dc.address.alternative | Department of Urology, Cancer Institute Hospital. | en |
dc.identifier.pmid | 12229181 | - |
dcterms.accessRights | open access | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.48 No.7 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。